Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization

BACKGROUND: Stereotactic ablative radiotherapy (SABR) can deliver tumoricidal doses and achieve long-term control in early hepatocellular carcinoma (HCC). However, limited studies have investigated the safety and effectiveness of SABR in patients with advanced diseases that is unsuitable for transar...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Adv Med Oncol
Hlavní autoři: Lee, Hsin-Lun, Tsai, Jo-Ting, Chen, Chun-You, Lin, Ying-Chun, Ho, Chin-Beng, Ting, Lai-Lei, Kuo, Chia-Chun, Lai, I-Chun, Lin, Chun-Yu, Tang, Jui-Hsiang, Huang, Yu-Min, Kao, Wei-Yu, Cheng, Sheng-Wei, Shen, Chia-Ning, Chen, Shang-Wen, Chiou, Jeng-Fong
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2019
Témata:
Early Diagnosis and Therapeutic Advances for Liver Cancer: From Bench to Bedside
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6893933/
https://ncbi.nlm.nih.gov/pubmed/31839809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919889002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky